What Researchers Did
Researchers reviewed the current literature on the use of hyperbaric oxygen therapy as an adjunctive treatment for intracranial abscesses.
What They Found
Intracranial abscesses, including cerebral, subdural, and epidural empyema, are associated with high morbidity and mortality. The review suggests that hyperbaric oxygen therapy, being relatively non-invasive with a low complication rate, presents a favorable risk-benefit ratio for adjunctive use in selected patients with intracranial abscess.
What This Means for Canadian Patients
For Canadian patients diagnosed with intracranial abscesses, hyperbaric oxygen therapy could serve as a valuable adjunctive treatment option. This non-invasive approach may help improve patient outcomes by reducing morbidity and mortality associated with these severe infections.
Canadian Relevance
This review does not have a specific Canadian connection.
Study Limitations
As a narrative review, this study's findings are based on existing literature and do not include new primary data or a systematic analysis of evidence.